Poland· PL-100400021
VeraSeal
A local hemostatics product containing fibrinogenum humanum + trombinum humanum, registered in Poland by Instituto Grifols, S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fibrinogenum humanum + trombinum humanum is registered in 7 of 19 countries.
Countries holding a registration under ATC B02BC (local hemostatics), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Fibrinogenum humanum + trombinum humanum · ATC B02BC
7 / 19 countries
- Belgiumprice
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Fibrinogenum humanum + Trombinum humanum
- Manufacturer
- Instituto Grifols, S.A.
- Country
- Poland (PL)
- ATC code
- B02BC
- ATC class
- Local hemostatics
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BC
Local hemostatics, as other registers publish it.
- IrelandARTISS Solutions for Sealant, deep frozenBaxter Holding B.V.
- BelgiumEvicel 100 mg - 180 mg - 1600 IU - 2400 IUOmrix Biopharmaceuticals
- BelgiumEvicel 250 mg - 450 mg - 4000 IU - 6000 IUOmrix Biopharmaceuticals
- BelgiumEvicel 50 mg - 90 mg - 800 IU - 1200 IUOmrix Biopharmaceuticals
- NorwayJärnklorid aplApoteket Produktion & Laboratorier
- FinlandTisseel LyoBaxter AG
- IrelandTISSEEL Lyo Powder and Solvent for SealantBaxter Holding B.V.
- IrelandTISSEEL Ready to use Solutions for SealantBaxter Holding B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3e2bc4f7-8d23-4149-aae2-dc639913dcec GET /v1/drugs/3e2bc4f7-8d23-4149-aae2-dc639913dcec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do sporządzania kleju do tkanek",
"source": "urpl",
"strength": "80 mg/ml + 500 j.m./ml",
"packaging": "Rpz ¦ EU/1/17/1239/003 ¦ 126433\n2 amp.-strzyk. 3 ml\nRpz ¦ EU/1/17/1239/004 ¦ 126434\n2 amp.-strzyk. 5 ml\nRpz ¦ EU/1/17/1239/001 ¦ 126435\n2 amp.-strzyk. 1 ml\nRpz ¦ EU/1/17/1239/002 ¦ 126436\n2 amp.-strzyk. 2 ml",
"substance": "Fibrinogenum humanum 80 mg/ml + Trombinum humanum 500 j.m./ml",
"common_name": "Fibrinogenum humanum + Trombinum humanum",
"pl_product_id": "100400021",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about fibrinogenum humanum + trombinum humanum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.